Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Reapplix APS

This article was originally published in Start Up

Executive Summary

When the healing process for chronic wounds like diabetic foot ulcers stalls, something must be done to prevent infection and amputation. Out of Denmark, Reapplix APS has a bedside device for creating a three-layered biological patch out of a patient's own blood, without additives, and within 20 minutes.
Advertisement

Related Content

People Briefs: Wright Medical; Reapplix APS; Sotera Wireless
Start-Up Previews
Start-Up Previews
Patient-Centric Devices Promise Cost-Efficient Advanced Wound Care
Biologics: The Growth Engine in Advanced Wound Care
Wound Care Devices: Growth Amid Uncertainty
The Rebirth of Dermagraft
Advanced Wound Care: The Device Industry's New Billion Dollar Product Market

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT037736

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel